VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions

Molecular Biology of the Cell

Volumn 25, Issue 16, 2014, Pages 2509-2521

  Fearnley, Gareth W ^a   Odell, Adam F ^a   Latham, Antony M ^a   Mughal, Nadeem A ^a,b   Bruns, Alexander F ^c   Burgoyne, Nicholas J ^d   Homer Vanniasinkam, Shervanthi ^b   Zachary, Ian C ^e   Hollstein, Monica C ^f   Wheatcroft, Stephen B ^c   Ponnambalam, Sreenivasan ^a  

^a Endothelial Cell Biology Unit School of Molecular and Cellular Biology   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Fios Genomics Ltd   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN A; ATF2 PROTEIN, HUMAN; ISOPROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVERSE GENETICS; SIGNAL TRANSDUCTION; UBIQUITINATION; UMBILICAL VEIN ENDOTHELIAL CELL; CELL MOTION; GENETICS; METABOLISM; PHOSPHORYLATION;

ACTIVATING TRANSCRIPTION FACTOR 2; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; HUMANS; LEUKOCYTES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PROTEIN ISOFORMS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84905970103     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-05-0962     Document Type: Article

References (68)

1. Abid MR, Nadeau RJ, Spokes KC, Minami T, Li D, Shih SC, Aird WC (2008). Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 28, 2042-2048.
2. Abid MR, Shih SC, Otu HH, Spokes KC, Okada Y, Curiel DT, Minami T, Aird WC (2006). A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J Biol Chem 281, 35544-35553. (Pubitemid 46043252)
3. Arthur JS (2008). MSK activation and physiological roles. Front Biosci 13, 5866-5879.
4. Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D'Amico G, Jones DT, Vojnovic B, Hodivala-Dilke K (2012). Use of the mouse aortic ring assay to study angiogenesis. Nature Prot 7, 89-104.
5. Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB (2003). VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17, 1562-1564.
6. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ (2002). VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62, 4123-4131. (Pubitemid 34791084)
7. Bruns AF, Bao L, Walker JH, Ponnambalam S (2009). VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis. Biochem Soc Trans 37, 1193-1197.
8. Bruns AF, Herbert SP, Odell AF, Jopling HM, Hooper NM, Zachary IC, Walker JH, Ponnambalam S (2010). Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis. Traffic 11, 161-174.
9. Butler JM, Kobayashi H, Rafii S (2010). Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 10, 138-146.
10. Carmeliet P et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439. (Pubitemid 26102719)
11. Chen TT, Luque A, Lee S, Anderson SM, Segura T, Iruela-Arispe ML (2010). Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J Cell Biol 188, 595-609.
12. Chung AS, Ferrara N (2011). Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27, 563-584.
13. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9, 899-909.
14. Cuhlmann S et al. (2011). Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-KB regulation that promotes arterial inflammation. Circ Res 108, 950-959.
15. Dejana E, Taddei A, Randi AM (2007). Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta 1775, 298-312. (Pubitemid 46899342)
16. Delcombel R et al. (2013). New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis 16, 353-371.
17. Ding BS et al. (2010). Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468, 310-315.
18. Ewan LC, Jopling HM, Jia H, Mittar S, Bagherzadeh A, Howell GJ, Walker JH, Zachary IC, Ponnambalam S (2006). Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic 7, 1270-1282. (Pubitemid 44204001)
19. Fearnley GW, Smith GA, Odell AF, Latham AM, Wheatcroft SB, Harrison MA, Tomlinson DC, Ponnambalam S (2014). Vascular endothelial growth factor a-stimulated signaling from endosomes in primary endothelial cells. Methods Enzymol 535, 265-292.
20. Gerits N, Kostenko S, Shiryaev A, Johannessen M, Moens U (2008). Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: comradeship and hostility. Cell Signal 20, 1592-1607.
21. Goddard LM, Iruela-Arispe ML (2013). Cellular and molecular regulation of vascular permeability. Thromb Haemost 109, 407-415.
22. Griffioen AW, Molema G (2000). Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharm Rev 52, 237-268. (Pubitemid 30368433)
23. Harper SJ, Bates DO (2008). VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 8, 880-887.
24. Herve MA, Buteau-Lozano H, Mourah S, Calvo F, Perrot-Applanat M (2005). VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. Exp Cell Res 309, 24-31. (Pubitemid 41191220)
25. Herzog B, Pellet-Many C, Britton G, Hartzoulakis B, Zachary IC (2011). VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol Biol Cell 22, 2766-2776.
26. Holmqvist K, Cross MJ, Rolny C, Hagerkvist R, Rahimi N, Matsumoto T, Claesson-Welsh L, Welsh M (2004). The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279, 22267-22275. (Pubitemid 38679423)
27. Hordijk PL (2006). Endothelial signalling events during leukocyte transmigration. FEBS J 273, 4408-4415.
28. Horowitz A, Seerapu HR (2012). Regulation of VEGF signaling by membrane traffic. Cell Signal 24, 1810-1820.
29. Howell GJ et al. (2004). Endothelial cell confluence regulates Weibel-Palade body formation. Mol Membr Biol 21, 413-421. (Pubitemid 40030217)
30. Jain RK, Koenig GC, Dellian M, Fukumura D, Munn LL, Melder RJ (1996). Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev 15, 195-204. (Pubitemid 26236117)
31. Jopling HM, Howell GJ, Gamper N, Ponnambalam S (2011). The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling. Biochem Biophys Res Commun 410, 170-176.
32. Jopling HM, Odell A, Hooper NM, Zachary IC, Walker JH, Ponnambalam S (2009). Rab GTPase Regulation of VEGFR2 trafficking and signaling in endothelial cells. Arterioscler Thromb Vasc Biol 29, 1119-1124.
33. Karihaloo A, Karumanchi SA, Cantley WL, Venkatesha S, Cantley LG, Kale S (2005). Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion. Mol Cell Biol 25, 7441-7448. (Pubitemid 41170108)
34. Kawasaki H, Schiltz L, Chiu R, Itakura K, Taira K, Nakatani Y, Yokoyama KK (2000). ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405, 195-200. (Pubitemid 30313539)
35. Kawasaki H, Song J, Eckner R, Ugai H, Chiu R, Taira K, Shi Y, Jones N, Yokoyama KK (1998). p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev 12, 233-245. (Pubitemid 28060453)
36. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N (1996). The carboxylterminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271, 7788-7795. (Pubitemid 26111064)
37. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY (2001a). Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276, 7614-7620.
38. Kim I, Moon SO, Park SK, Chae SW, Koh GY (2001b). Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89, 477-479. (Pubitemid 34132640)
39. Koch S, Claesson-Welsh L (2012). Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2, a006502.
40. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011). Signal transduction by vascular endothelial growth factor receptors. Biochem J 437, 169-183.
41. Lau E, Ronai ZA (2012). ATF2-at the crossroad of nuclear and cytosolic functions. J Cell Sci 125, 2815-2824.
42. Lemmon MA, Schlessinger J (2010). Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134.
43. Liu D, Jia H, Holmes DI, Stannard A, Zachary I (2003). Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 23, 2002-2007. (Pubitemid 37433192)
44. Meadows KL, Hurwitz HI (2012). Anti-VEGF therapies in the clinic. Cold Spring Harb Perspect Med 2, a006577.
45. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK (1996). During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2, 992-997. (Pubitemid 26306837)
46. Nakatsu MN, Sainson RC, Perez-del-Pulgar S, Aoto JN, Aitkenhead M, Taylor KL, Carpenter PM, Hughes CC (2003). VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab Invest 83, 1873-1885. (Pubitemid 38018551)
47. Nakayama M, Berger P (2013). Coordination of VEGF receptor trafficking and signaling by coreceptors. Exp Cell Res 319, 1340-1347.
48. Naldini A, Carraro F (2005). Role of inflammatory mediators in angiogenesis. Curr Drug Targets 4, 3-8. (Pubitemid 40584847)
49. Nourshargh S, Hordijk PL, Sixt M (2010). Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 11, 366-378.
50. Pan Q et al. (2007). Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11, 53-67. (Pubitemid 46054517)
51. Panne D, Maniatis T, Harrison SC (2004). Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J 23, 4384-4393. (Pubitemid 39601963)
52. Plotnikov A, Zehorai E, Procaccia S, Seger R (2011). The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813, 1619-1633.
53. Reglero-Real N, Marcos-Ramiro B, Millan J (2012). Endothelial membrane reorganization during leukocyte extravasation. Cell Mol Life Sci 69, 3079-3099.
54. Reimold AM, Kim J, Finberg R, Glimcher LH (2001). Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. Int Immunol 13, 241-248. (Pubitemid 32123958)
55. Rivera CG, Mellberg S, Claesson-Welsh L, Bader JS, Popel AS (2011). Analysis of VEGF-a regulated gene expression in endothelial cells to identify genes linked to angiogenesis. PLoS One 6, e24887.
56. Salameh A, Galvagni F, Anselmi F, De Clemente C, Orlandini M, Oliviero S (2010). Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL. J Biol Chem 285, 23096-23104.
57. Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H, Wagner O, Bilban M, Hofer E (2009). The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 102, 544-554.
58. Seko Y, Takahashi N, Tobe K, Ueki K, Kadowaki T, Yazaki Y (1998). Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes. J Cell Physiol 175, 239-246. (Pubitemid 28198203)
59. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
60. Sixt M, Bauer M, Lammermann T, Fassler R (2006). Beta1 integrins: zip codes and signaling relay for blood cells. Curr Opin Cell Biol 18, 482-490. (Pubitemid 44332911)
61. Stannard AK, Khurana R, Evans IM, Sofra V, Holmes DI, Zachary I (2007). Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 27, 494-502.
62. Takahashi T, Yamaguchi S, Chida K, Shibuya M (2001). A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 20, 2768-2778. (Pubitemid 32938560)
63. Testori J et al. (2011). The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells. Blood 117, 2735-2744.
64. Usui T et al. (2004). VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest Ophthalmol Vis Sci 45, 368-374. (Pubitemid 38140491)
65. Weber C (1996). Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction. Immunol Res 15, 30-37.
66. Xu D, Fuster MM, Lawrence R, Esko JD (2011). Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J Biol Chem 286, 737-745.
67. Zhang Y, Furumura M, Morita E (2008). Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165. Growth Factors 26, 125-131. (Pubitemid 351911394)
68. Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R (2000). The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83, 63-68. (Pubitemid 30352718)